XML 30 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Stockholders' Equity / (Deficit) - USD ($)
$ in Thousands
Total
Sorrento
Legacy Common Stock
Common Stock
Preferred Stock Member
Additional Paid-in Capital
Additional Paid-in Capital
Sorrento
Accumulated Deficit
Accumulated Deficit
Sorrento
Balance at Dec. 31, 2019 $ (90,029)   $ 20 $ 0 $ 0 $ 126,578   $ (216,607)  
Balance (in Shares) at Dec. 31, 2019     197,310 0 0        
Stock options exercised value $ 50         50      
Stock options exercised (in shares) 38     38          
Stock-based compensation $ 5,395         5,395      
Recapitalization DueToThe Business Combination Shares     (197,310) 132,888          
Recapitalization Due to the Business Combination Value 20   $ (20) $ 13   7      
Distribution to sorrentos   $ (9,600)         $ (9,600)   $ 0
Cancellation of ordinary shares (in Shares)       (68)          
Net income (loss) (47,519)             (47,519)  
Effect of business combination in value (90,009)     $ 13   126,585   (216,607)  
Effect of business combination (in Shares)       132,888          
Balance at Dec. 31, 2020 $ (141,683)     $ 13   122,430   (264,126)  
Balance (in Shares) at Dec. 31, 2020       132,858          
Stock options exercised (in shares) 0                
Stock-based compensation $ 5,822         5,822      
Adjustment to shares issued in Semnur Acquisition 409         409      
Net income (loss) (88,424)             (88,424)  
Balance at Dec. 31, 2021 (223,876)     $ 13 $ 0 128,661   (352,550)  
Balance (in Shares) at Dec. 31, 2021       132,858 0        
Stock options exercised value 96         96      
Stock options exercised (in shares)       202          
Stock-based compensation 1,355         1,355      
Net income (loss) (9,143)             (9,143)  
Balance at Mar. 31, 2022 (231,568)     $ 13 $ 0 130,112   (361,693)  
Balance (in Shares) at Mar. 31, 2022       133,060 0        
Balance at Dec. 31, 2021 (223,876)     $ 13 $ 0 128,661   (352,550)  
Balance (in Shares) at Dec. 31, 2021       132,858 0        
Stock options exercised value $ 96         96      
Stock options exercised (in shares) 202     202          
Stock-based compensation $ 5,280         5,280      
Shares issued pursuant to the terms of the Debt Exchange Agreement, (In shares)       2,906 29,057        
Shares issued pursuant to the terms of the Debt Exchange Agreement 289,733       $ 3 289,730      
Shares issued as a result of the Business Combination, net of transaction activities (In Shares)       5,133          
Shares issued as a result of the Business Combination, net of transaction activities (8,706)     $ 1   (8,707)      
Adjustment To Additional Paid In Capital License Transfer Net Of Discount, value (4,127)         (4,127)      
Aardvark SP-104 license transfer from Sorrento (35)         (35)      
Shares issued to Yorkville pursuant to Yorkville Purchase Agreement (In Shares)       250          
Shares issued to Yorkville pursuant to Yorkville Purchase Agreement 1,238         1,238      
Net income (loss) (23,364)             (23,364)  
Balance at Dec. 31, 2022 36,239     $ 14 $ 3 412,136   (375,914)  
Balance (in Shares) at Dec. 31, 2022       141,349 29,057        
Balance at Mar. 31, 2022 (231,568)     $ 13 $ 0 130,112   (361,693)  
Balance (in Shares) at Mar. 31, 2022       133,060 0        
Stock-based compensation 1,437         1,437      
Aardvark SP-104 license transfer from Sorrento (4,127)         (4,127)      
Net income (loss) (17,838)             (17,838)  
Balance at Jun. 30, 2022 (252,096)     $ 13 $ 0 127,422   (379,531)  
Balance (in Shares) at Jun. 30, 2022       133,060 0        
Balance at Dec. 31, 2022 36,239     $ 14 $ 3 412,136   (375,914)  
Balance (in Shares) at Dec. 31, 2022       141,349 29,057        
Shares issued under Standby Equity Purchase Agreements, value 1,869         1,869      
Shares issued under Standby Equity Purchase Agreements       462          
Retainer shares issued 1     $ 1          
Retainer share issued (in Shares)       4,000          
Stock-based compensation 3,720         3,720      
Net income (loss) (30,753)             (30,753)  
Balance at Mar. 31, 2023 11,076     $ 15 $ 3 417,725   (406,667)  
Balance (in Shares) at Mar. 31, 2023       145,811 29,057        
Balance at Dec. 31, 2022 $ 36,239     $ 14 $ 3 412,136   (375,914)  
Balance (in Shares) at Dec. 31, 2022       141,349 29,057        
Stock options exercised (in shares) 128                
Balance at Jun. 30, 2023 $ 10,417     $ 15 $ 3 443,715   (433,316)  
Balance (in Shares) at Jun. 30, 2023       148,700 29,057        
Balance at Mar. 31, 2023 11,076     $ 15 $ 3 417,725   (406,667)  
Balance (in Shares) at Mar. 31, 2023       145,811 29,057        
Shares issued under Standby Equity Purchase Agreements, value 13,925         13,925      
Shares issued under Standby Equity Purchase Agreements       2,084          
Stock options exercised value 222         222      
Stock options exercised (in shares)       128          
Stock-based compensation 3,587         3,587      
Net income (loss) (26,649)             (26,649)  
Conversion of convertible debentures into common stock, shares       632          
Conversion of convertible debentures into common stock, value 7,735         7,735      
Issuance of common stock upon warrants exercise, shares       45          
Issuance of common stock upon warrants exercise, value 521         521      
Balance at Jun. 30, 2023 $ 10,417     $ 15 $ 3 $ 443,715   $ (433,316)  
Balance (in Shares) at Jun. 30, 2023       148,700 29,057